๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Unresectable Locally Advanced or Metastatic Solid Tumors

A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors NCT07165067Phase 13 sites๐Ÿ“ Waratah๐Ÿ“ Brisbane๐Ÿ“ Melbourne AP Biosciences Inc. ยท Tests: AP601 A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Tampa Elevar Therapeutics ยท Tests: Lirafugratinib Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors NCT06963281Phase 19 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Fortvita Biologics (USA)Inc. ยท Tests: IBI3020 IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors NCT06974812Phase 1, Phase 23 sites๐Ÿ“ Fuzhou๐Ÿ“ Changsha๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI3014, IBI3014, IBI3014, IBI3014, IBI3014 A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors NCT07488676Phase 1, Phase 221 sites๐Ÿ“ Birmingham๐Ÿ“ Los Angeles๐Ÿ“ Miami Astellas Pharma Global Development, Inc. ยท Tests: ASP546C A Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors NCT05205850Phase 1, Phase 22 sites๐Ÿ“ Shanghai๐Ÿ“ Hangzhou RemeGen Co., Ltd. ยท Tests: RC118-ADC A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors NCT05923008Phase 1, Phase 21 site๐Ÿ“ Birtinya Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI130 A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors NCT07066657Phase 121 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Aurora ArriVent BioPharma, Inc. ยท Tests: MRG007, MRG007 and Bevacizumab Study of JK06 in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT06667960Phase 1, Phase 214 sites๐Ÿ“ Antwerp๐Ÿ“ Brussels๐Ÿ“ Ghent Salubris Biotherapeutics Inc ยท Tests: JK06 A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors NCT07094204Phase 120 sites๐Ÿ“ Santa Monica๐Ÿ“ Atlanta๐Ÿ“ Jefferson Astellas Pharma Inc ยท Tests: ASP5834, panitumumab A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors NCT06827613Phase 1, Phase 28 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Boston Marengo Therapeutics, Inc. ยท Tests: STAR0602, Sacituzumab Govitecan (SG) A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors NCT07105215Phase 1, Phase 239 sites๐Ÿ“ Beijing๐Ÿ“ Fuzhou๐Ÿ“ Fuzhou RemeGen Co., Ltd. ยท Tests: RC278 Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors NCT06418061Phase 11 site๐Ÿ“ Jinan Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI3005 A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors NCT07612189Phase 110 sites๐Ÿ“ Orlando๐Ÿ“ New York๐Ÿ“ Nashville NEOK Bio, Inc. ยท Tests: NEOK002, NEOK002 RDE A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) (Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors NCT05208047Phase 3126 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Tucson Cogent Biosciences, Inc. ยท Tests: CGT9486, CGT9486, Sunitinib, Sunitinib, Midazolam A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors NCT07612176Phase 19 sites๐Ÿ“ New York๐Ÿ“ Nashville๐Ÿ“ Austin NEOK Bio, Inc. ยท Tests: NEOK001, NEOK001 RDE A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer NCT06184035Phase 1, Phase 22 sites๐Ÿ“ Adelaide๐Ÿ“ Melbourne Spago Nanomedical AB ยท Tests: [177Lu]Lu-SN201 A First-in-human Study of IBI354 in Subjects with Locally Advanced Unresectable or Metastatic Solid Tumors NCT05636215Phase 1, Phase 26 sites๐Ÿ“ Randwick๐Ÿ“ Sydney๐Ÿ“ Sunshine Coast Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI354 A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06493864Phase 11 site๐Ÿ“ Shanghai Sichuan Baili Pharmaceutical Co., Ltd. ยท Tests: BL-B16D1 SG1906 for CLDN18.2-Positive Solid Tumors NCT05857332Phase 19 sites๐Ÿ“ Beijing๐Ÿ“ Xiamen๐Ÿ“ Guangzhou Hangzhou Sumgen Biotech Co., Ltd. ยท Tests: SG1906 A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body NCT06413680Phase 1, Phase 211 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ North Haven Regeneron Pharmaceuticals ยท Tests: REGN10597, Cemiplimab Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer NCT05098210Phase 11 site๐Ÿ“ Seattle Fred Hutchinson Cancer Center ยท Tests: Neoantigen Peptide Vaccine, Nivolumab, Poly ICLC, Echocardiography Test, Multigated Acquisition Scan Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors NCT05706129Phase 1, Phase 210 sites๐Ÿ“ Melbourne๐Ÿ“ Sydney๐Ÿ“ Clermont-Ferrand Lumara Bio Oncologics GmbH ยท Tests: [68Ga]Ga-DPI-4452, [177Lu]Lu-DPI-4452 A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors NCT07730021Phase 1, Phase 24 sites๐Ÿ“ Lake Success๐Ÿ“ Fairfax๐Ÿ“ Chuo-ku Astellas Pharma Global Development, Inc. ยท Tests: ASP388B, Pembrolizumab, Carboplatin, Oxaliplatin, 5-fluorouracil A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors NCT05458219Phase 139 sites๐Ÿ“ Austin๐Ÿ“ Irving๐Ÿ“ San Antonio Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: IBI343, FOLFIRINOX/mFOLFIRINOX, mFOLFOX, IBI343 A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors NCT06016062Phase 1, Phase 231 sites๐Ÿ“ Anhui๐Ÿ“ Beijing๐Ÿ“ Beijing RemeGen Co., Ltd. ยท Tests: RC148 Monotherapy, RC148+docetaxel Combination Therapy, RC148+RC48 Combination Therapy, RC148+RC88 Combination Therapy,โ€ฆ Study of IBI3028 in Participants With Locally Advanced, Unresectable, or Metastatic Solid Tumors NCT07589205Phase 11 site๐Ÿ“ Tianjin Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD. ยท Tests: Drug: IBI3028 A Study of TAK-505 in Adults With Solid Tumors NCT07436728Phase 1, Phase 215 sites๐Ÿ“ Orange๐Ÿ“ San Diego๐Ÿ“ San Francisco Takeda ยท Tests: TAK-505
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy